Windtree Therapeutics Financial Overview
Windtree Therapeutics's market cap is currently $1.28M. The company's EPS TTM is $-1.085; its P/E ratio is >-0.01; Windtree Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
